Chasing TB Clusters – the role of molecular strain typing

Slides:



Advertisements
Similar presentations
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
Advertisements

Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Multi-drug Resistant Tuberculosis Hail M. Al-Abdely Consultant, Infectious Diseases, KFSH&RC.
Current technology- Molecular fingerprinting of Mycobacterium tuberculosis Andy Sails Regional Centre for Mycobacteriology Health Protection Agency Newcastle.
ISDH Lab TB Testing Update Lixia Liu PhD MP(ASCP) September 16, 2010.
Tuberculosis in the UK 2013 report
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
The Global Plan to Stop TB, (1)
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
TB typing and its impact on Public health in Wales Dr P. Lewis White Public Health Wales Microbiology Cardiff.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
TB Methodologies Dr. John G. Magee Regional Reference Centre for Mycobacteriology Health Protection Agency Regional Laboratory, Newcastle upon Tyne.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Overview: Molecular Epi
Current Health Concerns: Tuberculosis Saharwash Jamali Hamna Jaffar.
Understanding the impact of disease control: TB epidemiology and the GFATM.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
REMoxTB – a microbiological challenge Dr Anna Bateson Dr. Tim McHugh, Robert Hunt, Emma Cunningham (Emily Bongard, Holly Ciesielczuk)
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
National Tuberculosis Genotyping Service
TB Genotyping and Whole Genome Sequencing in California
SAGE 2010 Sampling Distribution
Palliative Care and M/XDR-TB Global burden of M/XDR-TB
financial requirements
World Tuberculosis Day 2014
reporting rate of discarded cases* per 100'000 population**
اپيدميولوژي و كنترل سِل
PROGRESS IN GLOBAL TB CONTROL
World Tuberculosis Day 2015
სასწავლო კურსი ოჯახის ექიმებისთვის ტუბერკულოზის ადრეული გამოვლენა და მართვა ზოგად საექიმო პრაქტიკაში სასწავლო პროგრამა ხორციელდება საოჯახო მედიცინის პროფესიონალთა.
A) IS6110 restriction fragment length polymorphism (RFLP) and b) spoligotyping patterns of a multidrug-resistant tuberculosis (MDR-TB) cluster. a) IS6110.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
SAGE 2009 Sampling Distribution
World Tuberculosis Day 2014
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Fast and low-cost decentralized surveillance of transmission of tuberculosis based on strain-specific PCRs tailored from whole genome sequencing data:
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
(70 countries or 36%) (23 countries or 12%)
Differences in the robustness of clusters involving the Mycobacterium tuberculosis strains most frequently isolated from immigrant cases in Madrid  N.
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
Investigation of suspected laboratory cross-contamination: interpretation of single smear-negative, positive cultures for Mycobacterium tuberculosis 
M.W. Borgdorff, D. van Soolingen  Clinical Microbiology and Infection 
Onset of most recent WPV1 Case Number of WPV infected districts
Countries having introduced HepB vaccine
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
S. Godreuil, F. Renaud, M. Choisy, J. J. Depina, E. Garnotel, M
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing  T.M. Walker, P. Monk, E. Grace Smith, T.E.A.
PROGRESS IN GLOBAL TB CONTROL
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
BCG Vaccination Dr Lika Nehaul CCDC / NPHS TB Programme Lead
Laura Lane, Epidemiologist
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

Chasing TB Clusters – the role of molecular strain typing NPHS Staff Conference 10th October 2007 Michael Ruddy Gwen Lowe Lika Nehaul

Introduction Background Epidemiology & laboratory role Overview of molecular strain typing M tb Outbreak control Summary

TB Clinical disease caused by Mycobacterium tuberculosis (M tb) “consumption” “Captain of the men of death” “Great white plague” Killed 1/4 Europeans 19th Century killed 1 billion worldwide in last 200 years

TB One third world infected (~2 billion) ~10% immune competent develop disease ~8 million new cases pa 2-3 million deaths pa major cause death 15-49 year olds (inc HIV) >95% burden in poorest countries

Estimated TB Incidence Rates, 2001 per 100 000 pop < 10 10 - 24 25 - 49 50 - 99 100 - 299 300 or more No estimate The designations employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. White lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2003

Percentage per tested cases Multi drug resistance (MDR), EU 2005 Percentage per tested cases Within the EU (27 countries), the Baltic states account for most of the MDR cases reported. In 2005, around 18% of all cases tested were MDR, while in other EU countries the percentage ranged between 0-6% XDR-TB cases have been also reported in the EU, and most of them were again reported from the Baltic States * Countries with incomplete data Source: EuroTB

TB Notifications England & Wales 1913-2005 Source: HPA ETS Sept 07

TB Notifications England & Wales 1982 to 2005 Source: HPA ETS Sept 07

TB Notifications UK By Region 2005 Source: HPA ETS Sept 07

Role of Laboratory Microscopy (ZN stain for AFB) Culture (solid & liquid) Identification (conventional & molecular) Drug sensitivity testing (conventional & molecular) “Serology” (gamma interferon testing) Molecular strain typing

Pink / red acid-fast bacilli seen in Ziehl-Neelsen stain of sputum. (M Pink / red acid-fast bacilli seen in Ziehl-Neelsen stain of sputum. (M.Tb)

M.kansasii (left) and M.tuberculosis (right) growing on LJ media Phenotypic tests M.kansasii (left) and M.tuberculosis (right) growing on LJ media

Mtb Typing: Why perform? Local outbreak investigation (confirm suspected epidemiological links) Detect unknown links – targeted interventions Exclude lab cross contamination Detect emergence of new strains Detect globally prevalent strains (?inform vaccine strategies/treatment protocols)

Which molecular method? Reproducibility No. of types RFLP 100% 84 Mixed-linker PCR 81 Spoligotyping 94% 61 DRE – PCR 58% 63 ETR – VNTR 97% 56 MIRU – VNTR 78 Mostrom et al 2002

RFLP (restriction fragment length polymorphism) The Reference Method RFLP DNA genotyping profiles of a series of M. tuberculosis isolates for direct visual and computer-assisted assessment of position and number of bands on the gel.

MIRU-VNTR Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeats Mini satellite regions of repeating sequences of nucleotides ?function, highly conserved Number of times the sequence repeats at each region varies >40 such regions (MIRU) useful to type strains 15 specific loci adopted across UK

VNTR (variable number tandem repeats) – The Principle TAAGGGCCA (X3) TAAGGGCCA (X2) TAAGGGCCA (X1) Strain 1: 2 4 1 8 3 Strain 2: 3 3 1 4 4

ETR–A ETR-B ETR-C ETR-D ETR-E Digital Code for Strains generated by ETR – VNTR Strain 1 1 3 2 2 3 Strain 2 3 3 2 3 3

Typical MIRU VNTR results

Combined results ETR MIRU Isolate Patient A B C D E 2 4 10 16 20 23 24   ETR MIRU Isolate Patient A B C D E 2 4 10 16 20 23 24 26 27 31 39 40 3 1 5 6 7 F G - H

VNTR-MIRU Generate a 15 digit strain designation number Geographical incidence of TB isolates with 15-VNTR profile ‘422225435173533’, which corresponds to the Leicester outbreak strain. Generate a 15 digit strain designation number Collated in UK National database

Summary 1st April 2005 prospective MIRU-VNTR all M tb isolates WCM 15 digit strain type to local database (1000 isolates) Local – national – international datasets Beware false clusters! Lab – HPT teamwork vital Secondary typing (?additional 7 loci ?RFLP) “epidemiologically confirmed genotype cluster”

Acknowledgements Alan Paull Daniel Thomas Eleri Davies Gwen Lowe Gwyneth Samuel Kay Parry Lewis White Lika Nehaul Rhian Williams Robin Howe Sally Corden

The workplace cluster Large office- approx 2000 employees Case A- Smear positive –late shift Case B- Friend- late shift same floor Case C- Late shift different floor- family member with TB A/B/C been to same school- where large outbreak several years previously Case D –Late shift same floor

The workplace cluster-2 A +B +D same high prevalence back ground. A+D had BCG C – different high prevalence background- had BCG Office had recruit a friend policy- so clusters of individuals with links.

Hypotheses Cluster is coincidence (cases from high prevalence background where TB is much more common) First three cases (A/B/C) associated with school outbreak (infected from another case? Reactivation?) Fourth coincidence First two cases friends (A/B), so close contact, third infected from family member, fourth different strain Outbreak of TB in workplace

How typing helped Typing from A/C/D indistinguishable (no isolate from B) Family member of C had different typing Conclusion: workplace outbreak Typing influenced management Late shift on floor where A/B/D worked offered screening. No new cases detected. Subsequent work links identified for A/C/D